Ho Jun Seol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ho Jun Seol has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Do-Hyun Nam
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School, of Medicine, Seoul, Republic of Korea
12 shared publicationsJung-Il Lee
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School, of Medicine, Seoul, Republic of Korea
11 shared publications- Doo-Sik Kong
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
10 shared publications - Jung-Il Lee
Samsung Medical Center
10 shared publications - Do-Hyun Nam
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
7 shared publications Doo-Sik Kong
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
7 shared publications
Latest Publications
- Open Access
- 18 July 2025
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 21 (4) , 1-7
Tinnitus and Health-Related Quality of Life After Gamma Knife Radiosurgery for Vestibular Schwannoma
BACKGROUND: Tinnitus is a common symptom in patients with vestibular schwannoma (VS). The impact of Gamma Knife radiosurgery (GKRS) on tinnitus and the health-related quality of life (HRQoL) of patients with VS remains unclear. This study evaluated the effect of GKRS on HRQoL affected by tinnitus. METHODS: From December 2020 to April 2022, spontaneous VS patients who had no prior history of treatment and underwent their first GKRS in this period were analyzed. Subjective distress from tinnitus was measured by the Tinnitus Handicap Inventory (THI) and their HRQoL by 36-Item Short Form Survey Version 2 (SF-36v2). Pre-GKRS THI and SF-36v2 were obtained, and after GKRS, consecutive THI and SF-36v2 were obtained during the follow-up period. Bowker’s test, paired Student’s t-test, and Spearman’s correlation were used to analyze the changes in THI grade, SF-36v2 score, and the correlation between THI grade and SF-36v2 score. Factors affecting the THI grade change and SF-36v2 score were evaluated through univariate and multivariate models. RESULTS: Twenty of 34 patients showed serviceable hearing before GKRS. The median radiation dose of GKRS was 12.75 Gy (range, 12-21 Gy). Twenty-two of 33 patients demonstrated no change or worse THI grade after GKRS, but the change was not statistically significant (P =.34). However, with age, the odds ratio of THI improvement is 0.905 (95% CI 0.83-0.98, P=.02). Patients with serviceable hearing before GKRS displayed THI grade improvement (OR = 6.721; P = .03). Compared to those with pre-GKRS THI grade 1, grades 3 and 4 exhibited lower odds of THI improvement (OR =0.095; P=.0449). No significant change was noted in SF-36v2 scores after GKRS. A high THI grade was correlated with a low physical component score (P =.03) and mental component score (P=.0002) of SF-36v2. CONCLUSION: Although THI grade and SF-36v2 change before and after GKRS did not show statistical significance, several factors affected THI grade change. Moreover, the THI grade and SF-36v2 score had a significant negative correlation. Factors that may aggravate tinnitus and further impact HRQoL of VS patients should be taken into account when planning treatment and providing counseling to VS patients.
- 18 July 2025
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 21 (4) , 1-7
Open AccessTinnitus and Health-Related Quality of Life After Gamma Knife Radiosurgery for Vestibular Schwannoma
BACKGROUND: Tinnitus is a common symptom in patients with vestibular schwannoma (VS). The impact of Gamma Knife radiosurgery (GKRS) on tinnitus and the health-related quality of life (HRQoL) of patients with VS remains unclear. This study evaluated the effect of GKRS on HRQoL affected by tinnitus. METHODS: From December 2020 to April 2022, spontaneous VS patients who had no prior history of treatment and underwent their first GKRS in this period were analyzed. Subjective distress from tinnitus was measured by the Tinnitus Handicap Inventory (THI) and their HRQoL by 36-Item Short Form Survey Version 2 (SF-36v2). Pre-GKRS THI and SF-36v2 were obtained, and after GKRS, consecutive THI and SF-36v2 were obtained during the follow-up period. Bowker’s test, paired Student’s t-test, and Spearman’s correlation were used to analyze the changes in THI grade, SF-36v2 score, and the correlation between THI grade and SF-36v2 score. Factors affecting the THI grade change and SF-36v2 score were evaluated through univariate and multivariate models. RESULTS: Twenty of 34 patients showed serviceable hearing before GKRS. The median radiation dose of GKRS was 12.75 Gy (range, 12-21 Gy). Twenty-two of 33 patients demonstrated no change or worse THI grade after GKRS, but the change was not statistically significant (P =.34). However, with age, the odds ratio of THI improvement is 0.905 (95% CI 0.83-0.98, P=.02). Patients with serviceable hearing before GKRS displayed THI grade improvement (OR = 6.721; P = .03). Compared to those with pre-GKRS THI grade 1, grades 3 and 4 exhibited lower odds of THI improvement (OR =0.095; P=.0449). No significant change was noted in SF-36v2 scores after GKRS. A high THI grade was correlated with a low physical component score (P =.03) and mental component score (P=.0002) of SF-36v2. CONCLUSION: Although THI grade and SF-36v2 change before and after GKRS did not show statistical significance, several factors affected THI grade change. Moreover, the THI grade and SF-36v2 score had a significant negative correlation. Factors that may aggravate tinnitus and further impact HRQoL of VS patients should be taken into account when planning treatment and providing counseling to VS patients.
- Open Access
- 1 September 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (5) , 562-572
Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience
Objective : Bevacizumab is a feasible option for treating cerebral radiation necrosis (RN). We investigated the clinical outcome of RN after treatment with bevacizumab and factors related to the initial response and the sustained effect.Methods : Clinical data of 45 patients treated for symptomatic RN between September 2019 and February 2021 were retrospectively collected. Bevacizumab (7.5 mg/kg) was administered at 3-week intervals with a maximum four-cycle schedule. Changes in the lesions magnetic resonance image (MRI) scans were examined for the response evaluation. The subgroup analysis was performed based on the initial response and the long-term maintenance of the effect.Results : Of the 45 patients, 36 patients (80.0%) showed an initial response, and eight patients (17.8%) showed delayed worsening of the corresponding lesion. The non-responders showed a significantly higher incidence of diffusion restriction on MRI than the responders (100.0% vs. 25.0%, p<0.001). The delayed worsening group showed a significantly higher proportion of glioma pathology than the maintenance group (87.5% vs. 28.6%, p=0.005). Cumulative survival rates with sustained effect were significantly higher in the groups with non-glioma pathology (p=0.019) and the absence of diffusion restriction (p<0.001). Pathology of glioma and diffusion restriction in MRI were the independent risk factors for non-response or delayed worsening after initial response.Conclusion : The initial response of RN to bevacizumab was favorable, with improvement in four-fifths of the patients. However, a certain proportion of patients showed non-responsiveness or delayed exacerbations. Bevacizumab may be more effective in treating RN in patients with non-glioma pathology and without diffusion restriction in the MRI.
- 1 September 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (5) , 562-572
Open AccessEffect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience
Objective : Bevacizumab is a feasible option for treating cerebral radiation necrosis (RN). We investigated the clinical outcome of RN after treatment with bevacizumab and factors related to the initial response and the sustained effect.Methods : Clinical data of 45 patients treated for symptomatic RN between September 2019 and February 2021 were retrospectively collected. Bevacizumab (7.5 mg/kg) was administered at 3-week intervals with a maximum four-cycle schedule. Changes in the lesions magnetic resonance image (MRI) scans were examined for the response evaluation. The subgroup analysis was performed based on the initial response and the long-term maintenance of the effect.Results : Of the 45 patients, 36 patients (80.0%) showed an initial response, and eight patients (17.8%) showed delayed worsening of the corresponding lesion. The non-responders showed a significantly higher incidence of diffusion restriction on MRI than the responders (100.0% vs. 25.0%, p<0.001). The delayed worsening group showed a significantly higher proportion of glioma pathology than the maintenance group (87.5% vs. 28.6%, p=0.005). Cumulative survival rates with sustained effect were significantly higher in the groups with non-glioma pathology (p=0.019) and the absence of diffusion restriction (p<0.001). Pathology of glioma and diffusion restriction in MRI were the independent risk factors for non-response or delayed worsening after initial response.Conclusion : The initial response of RN to bevacizumab was favorable, with improvement in four-fifths of the patients. However, a certain proportion of patients showed non-responsiveness or delayed exacerbations. Bevacizumab may be more effective in treating RN in patients with non-glioma pathology and without diffusion restriction in the MRI.
- 28 March 2023
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 165 (5) , 1389-1400
A single-center prospective study regarding time to return to activities of daily living after craniotomy for brain tumors
Background There are few studies on the time to return to activities of daily living (ADL) after craniotomy in patients with brain tumors. This study aimed to investigate the duration before returning to ADLs after craniotomy for brain tumors and present data that can provide information and guidelines on the appropriate time needed. Methods Patients (n = 183 of 234) who underwent craniotomy for brain tumors between April 2021 and July 2021 capable of self-care upon discharge were enrolled, and data of 158 were collected. The start time of 85 ADL items was prospectively investigated for 4 months postoperatively, using the self-recording sheet. Results Over 89% and 87% of the patients performed basic ADL items within a month and instrumental ADL items within 2 months (medians: within 18 days), except for a few. Regarding work, 50% of the patients returned within 4 months. Washing hair with a wound was performed at 18 days of median value, after 4 months of dyeing/perming hair, 6 days of drinking coffee/tea, after 4 months of air travel, and 40 days of complementary and alternative medicine. In patients with infratentorial tumors or surgical problems, return times were much later for various items. Conclusions It is possible to provide practical information and guidelines on the duration to return to ADL after craniotomy in brain tumor patients. These study findings also reduce uncertainty about recovery and daily life and help patients return to their daily life at the appropriate time, thereby maintaining function and daily well-being after surgery.
- 28 March 2023
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 165 (5) , 1389-1400
A single-center prospective study regarding time to return to activities of daily living after craniotomy for brain tumors
Background There are few studies on the time to return to activities of daily living (ADL) after craniotomy in patients with brain tumors. This study aimed to investigate the duration before returning to ADLs after craniotomy for brain tumors and present data that can provide information and guidelines on the appropriate time needed. Methods Patients (n = 183 of 234) who underwent craniotomy for brain tumors between April 2021 and July 2021 capable of self-care upon discharge were enrolled, and data of 158 were collected. The start time of 85 ADL items was prospectively investigated for 4 months postoperatively, using the self-recording sheet. Results Over 89% and 87% of the patients performed basic ADL items within a month and instrumental ADL items within 2 months (medians: within 18 days), except for a few. Regarding work, 50% of the patients returned within 4 months. Washing hair with a wound was performed at 18 days of median value, after 4 months of dyeing/perming hair, 6 days of drinking coffee/tea, after 4 months of air travel, and 40 days of complementary and alternative medicine. In patients with infratentorial tumors or surgical problems, return times were much later for various items. Conclusions It is possible to provide practical information and guidelines on the duration to return to ADL after craniotomy in brain tumor patients. These study findings also reduce uncertainty about recovery and daily life and help patients return to their daily life at the appropriate time, thereby maintaining function and daily well-being after surgery.
- Open Access
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (2) , 94-103
Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
Kim N, et al. Yonsei Med J. 2023 Jan;64:e11. https://doi.org/10.3349/ymj.2022.0352
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (2) , 94-103
Open AccessClinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
Kim N, et al. Yonsei Med J. 2023 Jan;64:e11. https://doi.org/10.3349/ymj.2022.0352
- 22 October 2022
- Published by Elsevier in World Neurosurgery
- Vol. 169, e110-e113
Impact of Postural Changes on Sinonasal Pressure After Endoscopic Endonasal Surgery
- 22 October 2022
- Published by Elsevier in World Neurosurgery
- Vol. 169, e110-e113
Impact of Postural Changes on Sinonasal Pressure After Endoscopic Endonasal Surgery
- 27 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 166, e1-e10
Factors Associated with Acute Obstructive Hydrocephalus After Retrosigmoid Approach for Extra-Axial Cerebellopontine Angle Tumors
- 27 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 166, e1-e10
Factors Associated with Acute Obstructive Hydrocephalus After Retrosigmoid Approach for Extra-Axial Cerebellopontine Angle Tumors